Stocks
GlaxoSmithKline (GSK) P/BV US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/BV | ? | -6.57 | -6.57 | -13.1 | 23.3 | -18.5 | -9.10 | ||
| Changes by years, y/y, % | +138% | 0% | +100% | -277% | -179% | +35.6% | |||
GlaxoSmithKline. P/BV
GlaxoSmithKline. P/BV, changes, %
GlaxoSmithKline (GSK) P/BV US GAAP (quarter values) |
||||||||
| 2024Q2 | 2024Q1 | 2024Q3 | 2024Q2 | 2024Q3 | LTM ? | |||
| P/BV | ? | -9.74 | -9.91 | -10.9 | 21.2 | -10.9 | -9.10 | |
| Changes by years, y/y, % | -36% | -37% | +35% | -240% | +35% | |||
| Changes by quarters, q/q, % | -47% | +2% | +10% | -295% | -151% | |||
